News and Events

News

• Charles River Acquires Cellero August 5, 2020
  
  READ MORE
• HemaCare Adds GMPrime^TM Cryopreserved Leukopak to... June 2, 2020
  
  READ MORE
• Charles River Laboratories Completes the Acquisition of... January 3, 2020
  
  READ MORE
• Charles River Laboratories to Acquire HemaCare Corporation December 16, 2019
  
  READ MORE
• HemaCare Expands Its Product Portfolio with... November 19, 2019
  
  READ MORE
• HemaCare and Charles River Laboratories Partner to Provide... August 27, 2019
  
  READ MORE
• HemaCare Reports First Half 2019 Results August 20, 2019
  
  READ MORE
• HemaCare and Tissue Solutions Announce Strategic Partnership... March 28, 2019
  
  READ MORE
• HemaCare Reports Full Year 2018 Results March 26, 2019
  
  READ MORE
• HemaCare to Chair and Present at Phacilitate Leaders World... January 15, 2019
  
  READ MORE
• HemaCare Relocates Global Headquarters December 6, 2018
  
  READ MORE
• HemaCare Provides Starting Material For Three FDA Approved... November 14, 2018
  
  READ MORE
• HemaCare Details Expanded GMP Capabilities at CAR-TCR Summit... September 4, 2018
  
  READ MORE
• HemaCare Reports First Half 2018 Results August 21, 2018
  
  READ MORE
• HemaCare Expands Development of Cellular Therapy Services by... July 17, 2018
  
  READ MORE
• HemaCare Reports Full Year 2017 Results March 8, 2018
  
  READ MORE
• Notice of Annual Meeting of Shareholders Before Relocating... February 20, 2018
  
  READ MORE
• HemaCare and Charles River Laboratories Announce Strategic... February 6, 2018
  
  READ MORE
• HemaCare Announces OneBlood Exercises Second Investment... January 8, 2018
  
  READ MORE
• HemaCare Plays Mission Critical Role in Global Cellular... September 12, 2017
  
  READ MORE
• HemaCare Reports Strong First Half 2017 Results August 21, 2017
  
  READ MORE
• HemaCare Signs Long Term Lease for Facility Relocation and... July 24, 2017
  
  READ MORE
• HemaCare Announces Expansion of Disease State Cells for... July 17, 2017
  
  READ MORE
• HemaCare Reports Strong, Profitable 2016 Results March 13, 2017
  
  READ MORE
• HemaCare Signs Distribution Agreement with Israeli-Based... February 20, 2017
  
  READ MORE
• HemaCare and OneBlood Announce Innovative Partnership January 10, 2017
  
  READ MORE
• HemaCare Signs Distribution Agreement with Korea-Based... October 31, 2016
  
  READ MORE
• HemaCare Reports Strong First Half 2016 Results September 6, 2016
  
  READ MORE
• HemaCare Achieves Q2 Conference Goals July 11, 2016
  
  READ MORE
• HemaCare Signs Distribution Agreement with China-Based... May 12, 2016
  
  READ MORE
• HemaCare Reports Strong 2015 Results April 11, 2016
  
  READ MORE
• HemaCare Expands Its Offering of Stem Cell-Enriched... March 28, 2016
  
  READ MORE
• HemaCare to Increase Bone Marrow Capability March 21, 2016
  
  READ MORE
• HemaCare Committed to Cell Therapy Research Through... October 19, 2015
  
  READ MORE
• HemaCare Reports Strong First Half 2015 Revenue Growth September 21, 2015
  
  READ MORE

Events

• 
  Allogeneic Cell Therapies Summit

  Virtual Meeting

  HemaCare, a Charles River company, will be exhibiting and presenting at the Allogeneic Cell Therapies Summit 2021. Be sure to stop by the Keynote Clinical Case Studies session where Dr. Dominic Clarke will present How an Effective Source Material Supply Chain Can Enhance Scalability of Cell and Gene Therapies. Visit our virtual booth to learn more about our RUO and GMP products and services.

  May 17-19, 2021

  VISIT EVENT WEBSITE
• 
  ISCT 2021

  Virtual Meeting

  Join HemaCare, a Charles River company, where Dr. Dominic Clarke will be chairing and moderating the Allogeneic Therapies – What Really is a Healthy Donor? session on Wednesday, May 26^th  – 10:00 EDT. Be sure to stop by our interactive virtual booth to connect with us and learn more about how we can support the development of the next generation of cell therapies with our RUO and GMP products and services.

  May 26-28, 2021

  VISIT EVENT WEBSITE